SLC6A3 and Parkinson disease: Interestingly, after inhibiting Tregs with anti-CD25 and administering rTMS stimulation, the changes in the levels of Syt6, TLR4, TH and Slc6a3 in MPTP mouse brains were significantly reversed compared with those in the PD + rTMS group (Fig. 3F,G).